Before You Stop GLP 1s, Watch This Most People Regain скачать в хорошем качестве

Before You Stop GLP 1s, Watch This Most People Regain

Stopping GLP-1 medications like Ozempic, Wegovy, Zepbound, or Mounjaro is one of the most common questions patients ask after successful weight loss. But here’s the reality most people are not told clearly: When GLP-1 medications are stopped abruptly, appetite signaling often returns and weight regain can happen. This isn’t a failure of discipline. It’s biology. In this video, I explain the evidence-based GLP-1 exit strategy that helps reduce rebound weight gain and protect metabolic health. You’ll learn: • Who can safely taper off GLP-1 medications • Who should be cautious about stopping • The 5-step GLP-1 taper strategy used in metabolic medicine • Early warning signs of weight regain • How to stabilize metabolism before lowering your dose • The habits that protect weight loss long term GLP-1 medications reduce appetite and improve metabolic signaling — but obesity is a chronic metabolic condition, which means long-term strategy matters. The goal is not simply stopping medication. The goal is long-term metabolic stability. If you’re currently taking Ozempic, Wegovy, Zepbound, or Mounjaro, this video will help you understand how clinicians think about tapering, maintenance dosing, and preventing rebound weight gain. This video is educational only. Medication decisions should always be made with your own healthcare provider.